Kerry acquires C-LEcta and Enmex to fast track food and pharma biotechnologies
date:Feb 16, 2022
ng enzyme portfolio and build on its capacity to use enzymes in modifying cereals and grains.

Enmex is an enzyme manufacturer based in Mexico, supplying multiple bioprocess solutions for FB markets. The acquisition will extend Kerrys fermentation and enzyme manufacturing capabilities into Latin America, its largest market.

The company can now increase the breadth of enzymes it manufactures, by adding six additional six commercial enzyme producing strains and their manufacturing processes to i
4/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/24 08:06